Rare
lephants
Screener
Toggle theme
Replimune Group, Inc.
REPL
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Equity & Debt
Assets & Liabilities
Asset & Liabilities Breakdown
Balance Sheet
›
Equity & Debt
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Equity & Debt
Chart
Table
Long Term Debt
Share Holder Equity
Cash on Hand
Fiscal Year
Long Term Debt
Share Holder Equity
Cash on Hand
FY2026
$83.3M
$166.2M
$209.0M
Download CSV
